CLARKSON PHARMACY Trademark
Trademark Overview
On Friday, January 12, 2024, a trademark application was filed for CLARKSON PHARMACY with the United States Patent and Trademark Office. The USPTO has given the CLARKSON PHARMACY trademark a serial number of 98354631. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, August 9, 2024. This trademark is owned by CLARKSON PHARMACY LLC. The CLARKSON PHARMACY trademark is filed in the Advertising, Business and Retail Services category with the following description:
Pharmaceutical Retail Services
General Information
Serial Number | 98354631 |
Word Mark | CLARKSON PHARMACY |
Filing Date | Friday, January 12, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, August 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceutical Retail Services |
NOT AVAILABLE | "PHARMACY" |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 12, 2024 |
Primary Code | 035 |
First Use Anywhere Date | Thursday, August 1, 2019 |
First Use In Commerce Date | Thursday, August 1, 2019 |
Trademark Owner History
Party Name | CLARKSON PHARMACY LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Brooklyn, NY 11203 |
Trademark Events
Event Date | Event Description |
Friday, January 12, 2024 | NEW APPLICATION ENTERED |
Thursday, August 8, 2024 | ASSIGNED TO EXAMINER |
Friday, August 9, 2024 | NON-FINAL ACTION E-MAILED |
Friday, August 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, August 9, 2024 | NON-FINAL ACTION WRITTEN |
Sunday, May 5, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |